Shaily Engineering Tops Rs 3,404 Target on Healthcare Growth Hopes

BROKERAGE-REPORTS
Whalesbook Logo
AuthorAnanya Iyer|Published at:
Shaily Engineering Tops Rs 3,404 Target on Healthcare Growth Hopes
Overview

Motilal Oswal has started covering Shaily Engineering Plastics, setting a price target of INR 3,404, which suggests a 26% potential gain. The firm's strategy relies on fast growth in its high-margin healthcare division and increasing production of GLP-1 pens, although the stock is currently valued much higher than its industry peers.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Valuation Premium

Shaily Engineering Plastics is attracting significant investor attention. Motilal Oswal's 'Buy' rating and INR 3,404 price target signal strong institutional belief in the company's future. However, the stock's current price-to-earnings ratio of nearly 76x is considerably higher than the machinery industry average of about 36x. This suggests the market is betting on flawless execution of expansion plans rather than current earnings.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.